Figure 1.
MED1 alterations in breast cancer patients. (A,B) Genetic and transcriptomic alterations of MED1 in breast cancer patients. MED1 copy number variations and expression alterations were found in breast cancer patients from TCGA database (A). Copy number variations of MED1 locus are correlated to variations in MED1 mRNA expression levels (B). (C) MED1 expression is significantly associated to survival in breast cancer patients. Survival data were obtained from TCGA data portal for two datasets of BC patients analysed with microarray (top graphs) or RNA sequencing (bottom graphs). Both datasets confirmed a significant positive association between MED1 expression and Overall Survival in ER+ BC patients.